A Case of Cutaneous Plasmacytoma Treated with Bortezomib and Radiotherapy / 대한피부과학회지
Korean Journal of Dermatology
;
: 483-486, 2009.
Article
in Korean
| WPRIM
| ID: wpr-124177
ABSTRACT
Multiple myeloma is a hematologic malignancy characterized by the proliferation of monoclonal plasma cells that produce monoclonal immunoglobulins. Cutaneous involvement is very uncommon in patients with multiple myeloma. It usually appears late in the course of the disease. Bortezomib is a potent proteasome inhibitor, recently introduced in the treatment of multiple myeloma. It has proven to be safe and effective in the treatment of refractory or relapsed multiple myeloma. In this study, we show the high efficacy of a concurrent therapeutic approach with bortezomib and radiation in a patient with a cutaneous plasmacytoma.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Plasma Cells
/
Plasmacytoma
/
Pyrazines
/
Boronic Acids
/
Immunoglobulins
/
Hematologic Neoplasms
/
Proteasome Inhibitors
/
Bortezomib
/
Multiple Myeloma
Limits:
Humans
Language:
Korean
Journal:
Korean Journal of Dermatology
Year:
2009
Type:
Article
Similar
MEDLINE
...
LILACS
LIS